Commentary
Commentary
Goodbye, finger sticks; hello, CGMs
It’s easy to determine whether blood sugar is going up or down and the proportion of time the patient spends in or out of the target glucose range...
The Optimized Doctor
The sacred office space
Patients will be inconvenienced and pay higher costs to experience their appointment in person. This should not be surprising.
Managing Your Practice
Creating a fair time-off policy
Employees generally like the PTO concept, because most never use all of their sick leave.
Commentary
Alzheimer’s disease and the primary care physician
Developments in Alzheimer’s disease research are speeding ahead and give family physicians a bit more information to discuss with patients and...
Guidance for Practicing Primary Care
How the new depression screening guidelines in adults do little to address our mental health care crisis
It is good that screening is now recommended, but we need to do more to tear down the stigma attached to mental illness.
Commentary
The biggest mistake we could make with obesity drugs
Too often lost in news stories about the success of obesity drugs like tirzepatide and semaglutide is that research study participants also...
Commentary
10 ways docs sabotage their patients’ weight loss journeys
Stopping medications for obesity when weight is lost. Do you also stop blood pressure medications when they normalize a patient’s blood pressure...
Commentary
Lessons from the longest study on happiness
To some surprise, researchers determined that good relationships were the most significant predictor of health and happiness during aging.
Commentary
Does rapid weight loss from GLP-1s decrease muscle mass?
Providers prescribing medications like GLP-1 agonists to treat obesity must also counsel patients about incorporating aerobic exercise and...
Commentary
Has the time come to bury BMI in favor of other screening measures?
While BMI is a quick and inexpensive means to assess obesity, by itself it lacks the necessary components for an accurate diagnosis.
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...